Form 4 for DGX Quest Diagnostics
Accepted 2022-05-20 00:00:00 ET · period of report 2022-05-18 · accession 0001022079-22-000093 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-20 | 2022-05-18 | DGX | PFEIFFER GARY M | Dir | A - Grant | $0.00 | +1,292 | 25.0K | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-18 | A | A | 1,292 | $0.00 | 24,982 | D | — | — | (F1) Represents an award of restricted stock units. (F2) The amount includes approximately 425 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. |